California Labor Laboratory collaboration hub
Official title: California Labor Laboratory (CALL)
Funded at University of California, San Francisco · NIH-11623425 · Data updated 2026-11-12
A large research collaboration aimed at advancing understanding of how labor and employment factors affect health, with potential benefits for patients through healthier work environments and informed policies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 1, 2021 |
| Project end | August 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $1,152,555 |
| NIH project number | 6U19OH012293-05M003 |
| Project ID | NIH-11623425 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults experiencing health problems related to work conditions or those seeking conditions that may be improved by workplace interventions.
✕Less likely to help
Individuals without work-related health issues or those not impacted by labor conditions may see limited direct benefit.
What this research studies
This grant funds a multi-institution effort to study how labor conditions influence health outcomes. Researchers will coordinate across sites to collect data, analyze relationships between work environments and patient health, and share findings that could guide better clinical and workplace practices. The work may involve analyzing existing records, surveying participants, and integrating diverse data sources to inform patient care and public health strategies. If successful, it could help clinicians tailor care to patients affected by work-related health issues and support policies that reduce health risks at work.
Why it matters
Potential benefit: Better-informed clinical care and workplace policies could reduce health risks linked to labor conditions.
How similar studies have gone: Previous studies have linked labor conditions to health outcomes, and broader collaborations like this have shown promise in informing policy and care.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Harris Adamson, Carisa — University of California, San Francisco
- Study coordinator: Harris Adamson, Carisa
Related research
Other NIH-funded projects on the same topics.
-
How cancer cells use exosomes to evade the immune system
This study is looking at how cancer cells use tiny bubbles called exosomes to hide proteins that can keep your immune system from fighting the tumor, and by figuring this out, the researchers hope to help doctors understand why some people respond well to cancer treatments while others don’t, ultimately aiming to creat
-
Reducing harm from smoking using electronic cigarettes
This study is looking at whether using electronic cigarettes can be a safer option for people who smoke traditional cigarettes, by comparing the health effects and exposure to harmful substances between the two.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Cutaneous opioid signals in skin inflammation
A mentor-identified clinician-researcher at UCSF is studying how natural skin opioids regulate itch and pain in inflammatory skin conditions like eczema and hidradenitis, with plans to map where these opioids come from and how they affect skin nerves.
-
Pooling international data to understand long-term bisphosphonate use and atypical femur fractures
This project combines large patient datasets from multiple countries to understand how long-term bisphosphonate use relates to rare hip and thigh bone fractures, helping doctors and patients make safer treatment choices.
-
Airway cell and immune cell talks in lung transplant failure
This grant tests how airway cells and immune cells interact to drive chronic rejection after lung transplant, with the goal of slowing or preventing scar-like damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.